Breaking: Ministry of Health Admits Under-Reporting Of COVID-19 Vaccine-Associated Myocarditis & Pericarditis

In a 15th December 2021 communique to medical practitioners but not otherwise publicly released, the NZ Ministry of Health has admitted that the incidence of COVID-19 vaccine-associated myocarditis and pericarditis in NZ is likely to be under-reported. The letter is “urgent” and is in response to “recent reports of myocarditis/pericarditis following vaccination with Pfizer Comirnaty vaccine.”

The letter was found on the Royal New Zealand College of General Practitioners website rnzcgp.org.nz.

The letter states that “In New Zealand, the true incidence of vaccine-associated myocarditis is unknown as the onset of symptoms occurs in the first few days after vaccination and is potentially under-reported. However, the overall rate of this event in New Zealand is reported to be around 3 per 100,000 vaccinations.”

As at 15th December 2021, the Ministry of Health reported that 7,939,672 doses of COVID-19 vaccines had been administered. This would imply 238 cases reported. However, as at 20 November 2021, the most recent Medsafe Adverse Events of Special Interest report available, 277 incidences of myocarditis/pericarditis had been registered, with an additional 46 incidences of heart attacks. The figures as at 20th November already imply an overall rate that is higher than that stated in the letter.

The letter urges healthcare providers to support the government in “leading a response in your region, in partnership with primary care, urgent care, pharmacy, and other community organisations and providers. We need to ensure that consumers are well informed of this rare side effect and know when to seek help. We also want to ensure that the health system is poised to diagnose and clinically manage consumers with this condition appropriately.”

The Ministry’s letter goes on to state, “Serious complications of this condition are avoidable with timely assessment and treatment. A critical component to preventing the harm of vaccine-associated myocarditis/pericarditis is effective person-centred communication at point of vaccination. We know vaccinators and clinicians are excellent in describing the common and mild vaccine side-effects to consumers prior to vaccination as part of the consent conversation. However, informing consumers of the rare and serious potential side-effects (such as anaphylaxis, myocarditis and pericarditis) is also crucial.”

We recently reported on the unprecedented level of marketing & promotion of mass vaccination events that have been run in the last few months, particularly in Auckland. While the “common and mild” adverse effects are always mentioned by vaccinators, we are aware that aside from the requirement to remain under observation for 15 minutes post injection, recipients of the injections are rarely informed of the risk of serious side effects at the point of injection.

A recent document release by Pfizer as a result of a US Court order also revealed a very large array of previously unknown vaccine adverse effects compiled from official sources around the world. Pfizer concedes this is ‘a large increase’ in adverse event reports and that even this huge volume is under-reported.

With workplace and sporting vaccination mandates becoming more widespread, it is likely NZ will see an increase in the number of vaccine-associated myocarditis or pericarditis incidents.

 

Spread the Truth:
, , ,
Latest Stories

RELATED ARTICLES:

Menu